K991078 is an FDA 510(k) clearance for the ACCUSIGN DOA8, DOA8 PANEL, THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA8, THC/OPI/COC/AMP/BZO/BAR/TCA/PAP, STATUS DS DO8. This device is classified as a Reagents, Test, Tetrahydrocannabinol (Class II - Special Controls, product code DKE).
Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on April 15, 1999, 20 days after receiving the submission on March 26, 1999.
This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3870.
| 510(k) Number | K991078 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 26, 1999 |
| Decision Date | April 15, 1999 |
| Days to Decision | 20 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | DKE — Reagents, Test, Tetrahydrocannabinol |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.3870 |